The rise of precision medicine is transforming the healthcare landscape, offering personalised treatments based on genetic profiles, enhancing patient outcomes, and reducing costs. On Industry Insight, we explore how technologies like AI and big data are driving innovation in this space.

Gena Nikitin, CEO of Norway-based Miphic, joins us to share the latest trends and the future of personalised healthcare. Miphic is a pioneering company with a focus on mitochondrial health and precision medicine.